News
02-09-2010, 05:10 AM
ExThera Medical announced today that the results of a preliminary study (“Cytokines in blood from septic patients interact with surface immobilized heparin”) of its proprietary medical device, Seraph™ extracorporeal affinity therapy, have been published in the current issue of the Journal of the American Society for Artificial Organs (Jan.-Feb. 2010).
More... (http://www.news-medical.net/news/20100209/Preliminary-study-results-of-ExThera-Medicals-Seraph-extracorporeal-affinity-therapy-published.aspx)
More... (http://www.news-medical.net/news/20100209/Preliminary-study-results-of-ExThera-Medicals-Seraph-extracorporeal-affinity-therapy-published.aspx)